- Home
- RFIL vs INKT Comparison
RFIL vs INKT Comparison
Compare RFIL & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- INKT
- Stock Information
- Founded
- RFIL 1979
- INKT 2017
- Country
- RFIL United States
- INKT United States
- Employees
- RFIL N/A
- INKT N/A
- Industry
- RFIL Electrical Products
- INKT Medicinal Chemicals and Botanical Products
- Sector
- RFIL Technology
- INKT Health Care
- Exchange
- RFIL Nasdaq
- INKT Nasdaq
- Market Cap
- RFIL 43.0M
- INKT 30.6M
- IPO Year
- RFIL N/A
- INKT 2021
- Fundamental
- Price
- RFIL $4.07
- INKT $0.70
- Analyst Decision
- RFIL Strong Buy
- INKT Strong Buy
- Analyst Count
- RFIL 1
- INKT 1
- Target Price
- RFIL $4.50
- INKT $9.00
- AVG Volume (30 Days)
- RFIL 17.1K
- INKT 50.8K
- Earning Date
- RFIL 09-16-2024
- INKT 11-07-2024
- Dividend Yield
- RFIL N/A
- INKT N/A
- EPS Growth
- RFIL N/A
- INKT N/A
- EPS
- RFIL N/A
- INKT N/A
- Revenue
- RFIL $62,278,000.00
- INKT N/A
- Revenue This Year
- RFIL N/A
- INKT N/A
- Revenue Next Year
- RFIL $8.38
- INKT N/A
- P/E Ratio
- RFIL N/A
- INKT N/A
- Revenue Growth
- RFIL N/A
- INKT N/A
- 52 Week Low
- RFIL $2.51
- INKT $0.57
- 52 Week High
- RFIL $4.65
- INKT $1.90
- Technical
- Relative Strength Index (RSI)
- RFIL 53.18
- INKT 46.88
- Support Level
- RFIL $4.02
- INKT $0.65
- Resistance Level
- RFIL $4.14
- INKT $0.72
- Average True Range (ATR)
- RFIL 0.13
- INKT 0.05
- MACD
- RFIL -0.00
- INKT 0.00
- Stochastic Oscillator
- RFIL 56.10
- INKT 71.61
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.